Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.rpglifesciences.com | |
Market Cap | 2,530.80 Cr. | |
Enterprise Value(EV) | 2,507.79 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 51.25 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 29.85 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 219.00 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 6.99 | Calculated using Price: 1,530.20 |
Dividend Yield | 0.78 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.65 Cr. | 16,539,015 Shares |
FaceValue | 8 | |
About RPG Life Sciences Ltd. | ||
RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company's name was changed to RPG Life Sciences Ltd effective April 1, 1999.This company belongs to RPG group |
1 Day |
|
+3.90% |
1 Week |
|
+2.00% |
1 Month |
|
-2.11% |
3 Month |
|
+12.14% |
6 Month |
|
+16.43% |
1 Year |
|
+117.14% |
2 Year |
|
+165.90% |
5 Year |
|
+513.84% |
10 Year |
|
+2531.13% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.8 | 8.98 | 14.98 | 8.91 | 6.86 | 17.21 | 20.36 | 21.8 | 24.01 | |
Return on Capital Employed (%) | 2.5 | 8.97 | 15.58 | 12.52 | 9.81 | 20.35 | 27.27 | 31.46 | 32.92 | |
Return on Assets (%) | 0.47 | 5.34 | 9.15 | 5.17 | 4.07 | 11.25 | 14 | 15.89 | 17.71 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 125 | 134 | 147 | 155 | 161 | 177 | 216 | 256 | 308 | 336 | |
Non Curr. Liab. | 20 | 22 | 11 | 8 | 10 | 9 | 7 | 9 | 9 | 8 | |
Curr. Liab. | 67 | 67 | 79 | 121 | 78 | 83 | 80 | 80 | 103 | 117 | |
Minority Int. | |||||||||||
Equity & Liab. | 212 | 223 | 236 | 284 | 248 | 268 | 303 | 345 | 419 | 461 | |
Non Curr. Assets | 126 | 136 | 140 | 141 | 151 | 142 | 127 | 138 | 155 | 181 | |
Curr. Assets | 86 | 87 | 96 | 143 | 97 | 126 | 176 | 207 | 264 | 280 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 212 | 223 | 236 | 284 | 248 | 268 | 303 | 345 | 419 | 461 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 242 | 279 | 294 | 344 | 330 | 376 | 389 | 440 | 513 | 574 | |
Other Income | 7 | 2 | 10 | 2 | 1 | 1 | 1 | 3 | 5 | 7 | |
Total Income | 249 | 281 | 303 | 346 | 331 | 377 | 390 | 443 | 518 | 581 | |
Total Expenditure | -234 | -257 | -265 | -307 | -296 | -316 | -318 | -353 | -409 | -450 | |
PBIDT | 15 | 24 | 38 | 39 | 35 | 61 | 72 | 90 | 108 | 131 | |
Interest | -3 | -2 | -4 | -5 | -5 | -3 | -2 | -1 | -1 | 0 | |
Depreciation | -11 | -10 | -11 | -14 | -15 | -16 | -16 | -16 | -15 | -16 | |
Taxation | -2 | -7 | -4 | -7 | -14 | -22 | -24 | -29 | |||
Exceptional Items | -5 | ||||||||||
PAT | 1 | 12 | 21 | 13 | 11 | 29 | 40 | 51 | 68 | 85 | |
Adjusted EPS | 1 | 7 | 13 | 8 | 7 | 18 | 24 | 31 | 41 | 51 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -6 | -2 | 33 | 7 | 15 | 46 | 50 | 58 | 65 | 91 | |
Cash Fr. Inv. | 59 | -10 | -15 | -30 | -16 | -19 | -11 | -8 | -35 | -106 | |
Cash Fr. Finan. | -54 | 12 | -18 | 23 | 0 | -27 | -39 | -10 | -14 | -17 | |
Net Change | 0 | 0 | 0 | 1 | -1 | 0 | 0 | 40 | 17 | -32 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 40 | 57 | 25 |
Wed, 27 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith Loss of share certificate intimation received from the Registrar and share transfer agent dated March 27 2024. Kindly take the same on record |
Tue, 26 Mar 2024
Closure of Trading Window Company has informed about Trading Window Closure pursuant to SEBI(Prohibition of Insider Trading) Regulation 2015. |
Mon, 11 Mar 2024
Agreement For Subscription To Shares Execution of Share Subscription and Shareholders Agreement with Sunpound Solar Private Limited (Sunpound) Special Purpose Vehicle (SPV) for subscribing to at least 26% of the issued and paid up equity share capital of Sunpound in proportionate to the contracted capacity of corresponding captive generating power plant for value not exceeding Rs.1.10 crore.Details as per SEBI Circular dated July 13 2023 are enclosed as Annexure A.Kindly take the same on record. |
Thu, 28 Mar 2024 |
Close Crossing Last Month Close From Below |
Closing Above Previous High |
Close Within 52 Week High Zone |
Close Entering 52 Week High Zone |
Making Higher Highs for 2 Days |